OpenEvidence

Runs an AI clinical search and decision-support platform for physicians, free to doctors and funded by advertising.

View on the globe

$660MEquity raised in 2025–20262025 $410M · 2026 $250M · 3 equity rounds
$660MEquity raised, all time3 equity rounds on record
$12BLatest valuationpost-money, as reported

Rounds over time log-scaled amounts

Funding history: 3 rounds from 15 Jul 2025 to 21 Jan 2026, $660M equity disclosed, latest valuation $12B.15 Jul 2025: Series B, $210M, valued at $3.5B; 20 Oct 2025: Series C, $200M, valued at $6B; 21 Jan 2026: Series D, $250M, valued at $12B$100M$300M$1B$3B$10B$30BQ2Q3Q42026Q2Q3Equity roundPost-money valuation15 Jul 2025 · Series B · valued at $3.5B20 Oct 2025 · Series C · valued at $6B21 Jan 2026 · Series D · valued at $12B21 Jan 2026 · Series D · $250M at $12B · led by Thrive Capital, DST Global15 Jul 2025 · Series B · $210M at $3.5B · led by GV, Kleiner Perkins20 Oct 2025 · Series C · $200M at $6B · led by GV$12BSeries D · $250MSeries B · $210MSeries C · $200M
Funding history: 3 rounds from 15 Jul 2025 to 21 Jan 2026, $660M equity disclosed, latest valuation $12B.15 Jul 2025: Series B, $210M, valued at $3.5B; 20 Oct 2025: Series C, $200M, valued at $6B; 21 Jan 2026: Series D, $250M, valued at $12B$100M$300M$1B$3B$10B$30BQ2Q3Q42026Q2Q3Equity roundValuation15 Jul 2025 · Series B · valued at $3.5B20 Oct 2025 · Series C · valued at $6B21 Jan 2026 · Series D · valued at $12B21 Jan 2026 · Series D · $250M at $12B · led by Thrive Capital, DST Global15 Jul 2025 · Series B · $210M at $3.5B · led by GV, Kleiner Perkins20 Oct 2025 · Series C · $200M at $6B · led by GV$12B$250M$210M$200M

Funding history 3 rounds · 4 sources · newest first

  1. Series D
    Amount$250M
    Post-money$12B
    ✓ Confirmed
    Lead
    Thrive Capital, DST Global
    Also
    GV, Sequoia Capital, Nvidia, Kleiner Perkins, Blackstone, Coatue, BOND, Craft Ventures, Mayo Clinic
    Note
    A further $250M round at a $15B valuation was reported in September 2026 only via an aggregator citing Business Insider, so it is not recorded.
    Sources
  2. Series C
    Amount$200M
    Post-money$6B
    ◔ Reported
    Lead
    GV
    Also
    Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue, BOND, Craft Ventures
    Note
    TechCrunch reported the round (citing The New York Times) ahead of the company's announcement and gives the amount, valuation and GV lead; Crunchbase News later confirms the $6B Series C valuation but not the amount.
    Sources
  3. Series B
    Amount$210M
    Post-money$3.5B
    ✓ Confirmed
    Lead
    GV, Kleiner Perkins
    Also
    Sequoia Capital, Coatue, Conviction, Greycroft, Thrive Capital
    Note
    Company says Sequoia Capital led an earlier 2025 Series A; its amount and date are not stated, so it is not recorded.
    Sources

Investors 13

  • GV3
  • Kleiner Perkins3
  • Thrive Capital3
  • DST Global1
  • Coatue3
  • Sequoia Capital3
  • Blackstone2
  • BOND2
  • Craft Ventures2
  • Conviction
  • Greycroft
  • Mayo Clinic
  • Nvidia

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the Cambridge hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. OpenEvidence and its logo are trademarks of their owners, used here for identification only.